Antigen-specific B cell response regulation by IL-10–producing tolerogenic dendritic cells

B cells regulate immune responses via antibody production and antigen (Ag) presentation. Although B cell depletion is used therapeutically, it may be associated with side effects, highlighting the need for alternative B cell-targeted approaches. While tolerogenic dendritic cells (tolDC) are known to modulate T cell responses, their impact on B cells is poorly defined. We show that IL-10-producing tolDC (DC<sup>IL-10</sup>) regulate B cell responses through direct and indirect mechanisms. DC<sup>IL-10</sup> enhances T cell-independent human B cell proliferation and differentiation while suppressing Ag-specific memory B cells via T cell inhibition in vitro and dampen Ag-specific IgG production in preclinical humanized and murine models. These findings reveal a dual mechanism by which DC<sup>IL-10</sup> regulates B cell responses, broadening their application as a cell-based approach to treating immune-mediated diseases by targeting both B and T cells.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2025-11-21
DOI
https://doi.org/10.1126/sciadv.adu3624
Citations
1
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antigen-specific B cell response regulation by IL-10–producing tolerogenic dendritic cells

Francesca R. Santoni de Sio, S. Marieke van Ham, Juulke Steuten, Silvia Gregori et al.
1 citations
Science Advances
Immunotherapy and Immune Responses
0.80
article

Antigen-specific B cell response regulation by IL-10–producing tolerogenic dendritic cells

Francesca R. Santoni de Sio, S. Marieke van Ham, Juulke Steuten, Silvia Gregori, Fabio Russo, Konstantina Morali, Andrea Annoni, Anja ten Brinke, Charlotte Menage, Silvia Iaia, Valentina Consoli
article en
1 citations

Abstract

B cells regulate immune responses via antibody production and antigen (Ag) presentation. Although B cell depletion is used therapeutically, it may be associated with side effects, highlighting the need for alternative B cell-targeted approaches. While tolerogenic dendritic cells (tolDC) are known to modulate T cell responses, their impact on B cells is poorly defined. We show that IL-10-producing tolDC (DC<sup>IL-10</sup>) regulate B cell responses through direct and indirect mechanisms. DC<sup>IL-10</sup> enhances T cell-independent human B cell proliferation and differentiation while suppressing Ag-specific memory B cells via T cell inhibition in vitro and dampen Ag-specific IgG production in preclinical humanized and murine models. These findings reveal a dual mechanism by which DC<sup>IL-10</sup> regulates B cell responses, broadening their application as a cell-based approach to treating immune-mediated diseases by targeting both B and T cells.

Science AdvancesVol. 11(47)
Vita-Salute San Raffaele University (IT), Sanquin (NL), The San Raffaele Telethon Institute for Gene Therapy (IT), Amsterdam University Medical Centers (NL), University of Amsterdam (NL)
Openalex Percentile: Top 21%
Immunotherapy and Immune Responses
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Antigen-specific B cell response regulation by IL-10–producing tolerogenic dendritic cells — Francesca R. Santoni de Sio, S. Marieke van Ham, et al. · Science Advances (2025) | TGRS Research Map | TGRS